Bio-Techne Corp. Stock
Price
Target price
€58.50
€58.50
-1.690%
-1.0
-1.690%
€75.80
18.04.24 / Tradegate
WKN: A12ENG / Symbol: TECH / Name: Bio-Techne / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bio-Techne Corp. Stock
We can see a decrease in the price for Bio-Techne Corp.. Compared to yesterday it has lost -€1.000 (-1.690%).
With 8 Buy predictions and not the single Sell prediction the community is currently very high on Bio-Techne Corp..
With a target price of 75 € there is a positive potential of 28.21% for Bio-Techne Corp. compared to the current price of 58.5 €.
So far the community has only identified positive things for Bio-Techne Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Bio-Techne Corp. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Techne Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Techne Corp. | -1.690% | -10.000% | -12.030% | -24.026% | -17.606% | - | - |
| Neogen Corp. | -0.890% | -1.754% | -18.841% | -24.324% | -38.798% | -71.282% | -53.819% |
| Bio-Rad Labs Inc. A | -3.080% | -9.116% | -13.941% | -40.064% | -10.014% | -49.676% | - |
| Merit Medical Systems | -1.490% | -3.650% | 1.538% | -4.348% | -2.941% | 30.693% | 29.159% |
Comments
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Stephens from $92.00 to $87.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $80.00 price target on the stock.
Show more
Ratings data for TECH provided by MarketBeat
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Stifel Nicolaus from $104.00 to $65.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TECH provided by MarketBeat